2 completed, 1 available, 1 enrolling by invitation. 2 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Enrolling by invitation 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Plasminogen Deficiency, Type I: new trials by email Literature Review of Plasminogen Deficiency, Type I trials Research Report on Plasminogen Deficiency, Type I
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogenic Plasma Aliquots in the Treatment of Ligneous Conjunctivitis Allogenic plasma aliquots, a source of plasminogen - Ligneous Conjunctivitis, Left Eye | Phase 3 | Enrolling by invitation | Dorothy Bautista, MD | 1 | 2025-05-01 | 2024-11-22 |
| A Phase 1 Study of ProMetic Plasminogen (Human) Intravenous in Adults and Children With Plasminogen Deficiency Plasminogen (Human) Intravenous - Type I Plasminogen Deficiency, Hypoplasminogenemia | Phase 1 | Completed | Prometic Biotherapeutics, Inc. | 7 | 2014-12-01 | 2017-08-29 |
| Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients Human Plasminogen - Ligneous Conjunctivitis | Phase 2 / Phase 3 | Completed | Kedrion S.p.A. | 12 | 2013-05-22 | 2023-01-25 |
| Sponsor Initiated Expanded Access Protocol, Intermediate-Size Patient Population Plasminogen - Ligneous Conjunctivitis | Available | Kedrion S.p.A. | 2023-10-05 |
Congenital Plasminogen Deficiency (2)
Plasminogen (3)
Kedrion S.p.A. (2) · Dorothy Bautista, MD (1) · Prometic Biotherapeutics, Inc. (1)
United States (2) · Canada (1) · Italy (1)